Vitrasert

Active Ingredient(s): Ganciclovir
FDA Approved: * March 4, 1996
Pharm Company: * BAUSCH AND LOMB
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vitrasert Overview

Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections. Ganciclovir was patented in 1980 and approved for medical use in 1988.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 See also 6 References 7 Further reading 8 External links Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ...

Read more Vitrasert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ganciclovir

Recent Vitrasert Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ganciclovir
  • Capsule: 250mg, 500mg
  • Gel: 0.15%
  • Implant: 4.5mg
  • Injection: 2mg/ml, 500mg, 500mg/vial
  • Solution: 500mg/250ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ganciclovir or a similar ingredient: (5 results)